MedTrace Logo

Hereditary Haemorrhagic Telangiectasia Flight Safety Study

NCT01590121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2024-11-12

Study results available
· View outcomes & findings →

Summary

Hereditary Haemorrhagic Telangiectasia (HHT) is a condition in which sufferers have abnormal blood vessels which makes them more likely to bleed than other people, particularly in the lungs, which results in low blood oxygen levels. Flying may make this worse and cause problems. The investigators want to know if there are an increased number of problems on flights compared to on land.

The investigators currently do not have any evidence based guidelines on air travel to best advice people who suffer with HHT. The investigators would therefore like to ask individuals who have HHT about their experience on a flight, using a postal questionnaire.

Conditions

  • Hereditary Haemorrhagic Telangiectasia

Interventions

OTHER

Aeroplane flight in the past- no active intervention for study

Aeroplane flight(s) previously taken by study participants

OTHER

Questionnaire

Flight by aeroplane (previous)

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Claire L Shovlin, PhD MA MB BChir FRCP · Imperial College London

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01590121 on ClinicalTrials.gov